Financials

  • Market Capitalization 88.28 M
  • Employee 76
  • Founded 2018
  • CEO N/A
  • Website www.acrivon.com
  • Headquarter Massachusetts, United States
  • FIGI BBG011RWR2Q4
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.19
Price to sales ratio
464.04

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3986
ALDX
Aldeyra Therapeutics, Inc. - Common Stock
1.49 USD-3.25%-2.61%-8.59%-74.40%89.89 M USD
3995
RLYB
Rallybio Corporation - Common Stock
16.81 USD+0.30%+1.63%+5.66%+3132.69%89.27 M USD
4011
LNAI
Lunai Bioworks Inc. - Common Stock
2.37 USD+0.85%+9.72%+15.05%+52.90%85.96 M USD
4012
OKYO
OKYO Pharma Limited - American Depositary Shares
1.67 USD+7.74%+7.74%+2.45%-28.33%87.64 M USD

Frequently asked questions about Acrivon Therapeutics, Inc. Common Stock

What is the Acrivon Therapeutics, Inc. Common Stock stock price today?

The current price of Acrivon Therapeutics, Inc. Common Stock (ACRV) is 2.06. Over the past 24 hours, the stock has changed by -4.19%. Follow the ACRV chart for real-time price dynamics.

What is the stock ticker of Acrivon Therapeutics, Inc. Common Stock?

Acrivon Therapeutics, Inc. Common Stock trades under the ticker ACRV. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Acrivon Therapeutics, Inc. Common Stock stock going up?

ACRV has changed by -5.94% over the last week, +44.06% over the last month, and +57.25% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Acrivon Therapeutics, Inc. Common Stock?

Acrivon Therapeutics, Inc. Common Stock currently has a market capitalization of 88.28 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Acrivon Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Acrivon Therapeutics, Inc. Common Stock reported earnings of -0.43 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Acrivon Therapeutics, Inc. Common Stock net income for the last quarter?

Acrivon Therapeutics, Inc. Common Stock reported net income of -17.96 M for the last quarter. The previous quarter showed -19.04 M, which means net income changed by +5.66%.

How many employees does Acrivon Therapeutics, Inc. Common Stock have?

As of the latest available data, Acrivon Therapeutics, Inc. Common Stock has 76 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Acrivon Therapeutics, Inc. Common Stock stock?

You can buy Acrivon Therapeutics, Inc. Common Stock (ACRV) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Acrivon Therapeutics, Inc. Common Stock stock?

Investing in Acrivon Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ACRV chart and related analysis on metatrader.com as part of your research.

News